Cargando…
Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma
Glioblastoma (GBM) remains the most lethal and untreatable central nervous system malignancy. The challenges to devise novel and effective anti-tumor therapies include difficulty in locating the precise tumor border for complete surgical resection, and rapid regrowth of residual tumor tissue after s...
Autores principales: | Spencer, Drew, Yu, Dou, Morshed, Ramin A., Li, Gina, Pituch, Katarzyna C., Gao, David X., Bertolino, Nicola, Procissi, Daniele, Lesniak, Maciej S., Balyasnikova, Irina V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485287/ https://www.ncbi.nlm.nih.gov/pubmed/31037157 http://dx.doi.org/10.7150/thno.29581 |
Ejemplares similares
-
Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma
por: Dey, Mahua, et al.
Publicado: (2016) -
The potential of polymeric micelles in the context of glioblastoma therapy
por: Morshed, Ramin A., et al.
Publicado: (2013) -
MODL-12. DEVELOPMENT OF A NOVEL IMMUNOCOMPETENT MOUSE MODEL FOR DIFFUSE INTRINSIC PONTINE GLIOMA
por: Seblani, Maggie, et al.
Publicado: (2020) -
The use of anti-GITR antibody treatment in a murine model of glioblastoma multiforme
por: Miska, Jason, et al.
Publicado: (2015) -
Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma(☆)
por: Chung, Eun Ji, et al.
Publicado: (2013)